MASS · 908 Devices Inc.
$10.01
-0.10 (-0.99%)
At close · Aug 14
Market Cap
$413.75M
Shares
41.33M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.01
Open$10.26
Day$9.97–10.40
52W close$5.09–10.11
Avg vol 30d368K
Short int3.4M · 8.2% float · 11.0d
Short vol24%
Last earningsAug 11, 2026
DataDec 2020–Aug 2026
Filing10-Q · Aug 11
Up next
Next earnings call
Nov 19, 2026
Est · unconfirmed
· in 14 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+43%
above
Price vs 50-day avg
+20%
above
RSI (14)
74
overbought
MACD trend
Positive
52-week position
98%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+36%
trailing
6-month return
+54%
trailing
YTD return
+91%
this year
Relative strength
+40%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow
Distributing
-1% holders QoQ · +16 funds added
Insider flow
Distributing
Net -$2.5M over 90 days · 100% sells
Short interest
Rising
8.20% of float · ▲ +4.8% MoM · 11.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
111 holders — mid 3-yr range
Squeeze score
88
high risk · 0–100
Fundamentals
Revenue growth
+18%
Y/Y
Gross margin
51%
contracting
EPS growth
+125%
Y/Y
Free cash flow
$-24.6M
Balance sheet
$55.0M
net cash
Quant / Vol
risk profile
Volatility
64%
annualized · 1-yr
Max drawdown
−44%
past year
ATR
5.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Mar 3, 2026
Revenues
· full year 2026
$64.5M – $67.5M
Prior guidance
period ended
· from the Earnings Call filed Dec 31, 2024
Revenue from continuing operations
· 2025
$53M – $55M
Cash
· end of 2025
at least $110M
Guided vs delivered
· last 1 settled
Full year reported revenues
full year 2024
guided $63M – $65M
$47.75M
Miss −25.4%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+43%
Bullish
Price vs 50-day avg
+20%
Bullish
RSI (14)
74
Bearish
MACD trend
Positive
Bullish
52-week position
98%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow
Distributing
-1% holders QoQ · +16 funds added
Insider flow
Distributing
Net -$2.5M over 90 days · 100% sells
Short interest
Rising
8.20% of float · ▲ +4.8% MoM · 11.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
111 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $5
Now $10 · 98%
Range high $10
vs 200-day avg +43%
vs 50-day avg +20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA loss non-GAAP | $1.9M | Q2 2026 | — |
| Adjusted gross margin non-GAAP | 57% | Q2 2026 | — |
|
|
|||
| Devices placed | 198 | Q2 2026 | — |
|
|
|||
| Installed base | 4,101 | Q2 2026 | — |
|
|
|||
| Product placements (Handheld) | 198 | the three months ended June 30, 2026 filing | — |
| Recurring revenue | $4.9M | Q2 2026 | — |
| Adjusted EBITDA non-GAAP | -$9.6M | full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MASS
this stock
908 Devices Inc.
|
$413.75M | +90.7% | +17.7% | — | 8.2% |
|
ABT
Abbott Laboratories
|
$193.78B | -11.2% | +5.7% | 31.2 | 1.3% |
|
SYK
Stryker Corp
|
$130.11B | -3.5% | +11.2% | 35.2 | 2.2% |
|
MDT
Medtronic plc
|
$116.83B | -5.0% | +8.4% | 24.5 | 1.4% |
|
BSX
Boston Scientific Corp
|
$75.11B | -45.6% | +12.5% | 21.0 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MASS | +12.7% | +36.2% | +54.2% | +25.0% | +90.7% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +12.3% | +31.7% | +40.5% | +21.1% | +76.8% |
Key facts
CIK
1555279
CUSIP
65443P102
13F (30d)
113 filings
108 filers
Visit website
Investor relations